NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









QV Bioelectronics

QV Bioelectronics

Private
MacclesfieldHealthcare & Life Scienceshttps://www.qvbio.co.uk/

Last Round

Series A

Jan 21, 2026

Total Funding Raised

$15.67M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

QV Bioelectronics is a medical devices company developing an implantable electric field therapy (EFT) device for the treatment of aggressive brain tumours.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

glioblastoma treatmenttumor treating fieldsTTFieldsimplantable medical devicebioelectronicselectric field therapybrain cancer therapyneuro-oncologymedtechimplantable techcancer researchmedical device startupbio-electronic medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QV Bioelectronics Comps

Public and private peers based on sector, stage, and business model.

QV Bioelectronics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

QV Bioelectronics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 21, 2026
GrantMay 7, 2025
GrantAug 30, 2024
GrantMay 7, 2024
GrantAug 30, 2023
Grant
Apr 3, 2023

Key People

Founding team and executive leadership

Christopher Bullock

CEO Co-Founder

Founding Team

Sabine Ficek

Chief Financial Officer CFO

Executive Team

Carl Daintree

Chief Operating Officer

Executive Team

QV Bioelectronics Investors

Notable investors and investment history

QV Bioelectronics investors
InvestorRounds
Innovate UKGrant, Series A, Pre Seed
Consilience VenturesSeed
Fink Family OfficeEarly Funding
Elbow Beach CapitalEarly Funding
Empirical VenturesSeries A
Elbow Beach CapitalEarly Funding
Northern GritstoneEarly Funding

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors increased 48% MoM, reaching 1.3K.

  • Apr 16, 2026

    Grew 20% QoQ, from 15 to 18 employees.

QV Bioelectronics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

QV Bioelectronics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about QV Bioelectronics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMacclesfield
Employee Range19
Year Founded2018
Last FundingJan 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.